Pursuant to Regulation 34 of SEBI (LODR) 2015, attached herewith the 32nd Annual Report of the company
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Choksi Laboratories has filed its 32nd Annual Report for FY 2024-25 along with the AGM notice. Total revenue rose to Rs. 4,184.94 lakhs from Rs. 3,685.92 lakhs in the previous year, a growth of about 13.5%. Profit before tax climbed to Rs. 215.33 lakhs from Rs. 166.32 lakhs, and net profit after tax grew to Rs. 152.33 lakhs from Rs. 110.98 lakhs, an increase of around 37%. Basic EPS improved to Rs. 2.19 from Rs. 1.59. The board has not recommended any dividend, citing the need for funds for operations. The 32nd AGM is scheduled for September 16, 2025, via video conferencing, with items including approval of audited results, re-appointment of a Whole-Time Director, and appointment of a new Secretarial Auditor. The report also discloses a ransomware attack on May 22, 2025, that temporarily disrupted operations but was resolved by May 31, 2025.
Strong profit growth signals improving operational performance, though the absence of a dividend means shareholders will not receive a cash return for FY25. The cyberattack and quick recovery are worth noting but appear to have been managed without lasting financial damage.